×
0 0 0 0 0 0 -0.00167785234899331 -0.00167785234899331
Stockreport

CRISPR Could Cause Cancer? Here Are 3 Reasons Investors Shouldn't Panic [The Motley Fool]

CRISPR THERAPEUTICS AG COMMON SHARES (CRSP)  More Company Research Source: The Motley Fool
Last crispr therapeutics ag common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF Newly identified potential issues with CRISPR-Cas9 gene editing aren't as worrisome as you might think. First do no harm. That's a core principle for treating patients. But a promising gene-editing method called CRISPR-Cas9 could potentially harm patients. Two papers published in  Nature Medicine  on Monday raised concerns that using CRISPR-Cas9 to edit genes could increase the chances that cancer cells develop. The stocks of CRISPR Therapeutics ( NASDAQ:CRSP ) , Editas Medicine ( NASDAQ:EDIT ) , and Intellia Therapeutics ( NASDAQ:NTLA ) plunged on the news . All three of these biotechs are pioneering development of gene-editing therapies using CRISPR-Cas9. But should investors panic because of the possibility that CRISPR-Cas9 could cause cancer? Not at all. Here are three reasons why you should remain calm. Image source: Getty Images. 1. It's still early Do initial research findings in the scientific community sometimes prove to be inco [Read more]

IMPACT SNAPSHOT EVENT TIME: CRSP
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
CRSP alerts
from News Quantified
Opt-in for
CRSP alerts

from News Quantified
Opt-in for
CRSP alerts

from News Quantified